Tumors reveal their secrets to cytotoxic T cells
- 3 October 2006
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (40) , 14649-14650
- https://doi.org/10.1073/pnas.0606951103
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapyProceedings of the National Academy of Sciences, 2006
- Analysis of protein phosphorylation by mass spectrometryMethods, 2005
- Adoptive Immunotherapy for EBV-associated MalignanciesLeukemia & Lymphoma, 2005
- The Immunobiology of Cancer Immunosurveillance and ImmunoeditingImmunity, 2004
- Functional and Structural Characteristics of NY-ESO-1-related HLA A2-restricted Epitopes and the Design of a Novel Immunogenic AnalogueJournal of Biological Chemistry, 2004
- Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine designJournal of Peptide Science, 2003
- Cancer/testis antigens: an expanding family of targets for cancer immunotherapyImmunological Reviews, 2002
- Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in VivoThe Journal of Experimental Medicine, 2000
- Crystallography & NMR System: A New Software Suite for Macromolecular Structure DeterminationActa Crystallographica Section D-Biological Crystallography, 1998
- Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines.The Journal of Experimental Medicine, 1996